NIH study finds immunotherapy significantly increases survival for people with lymphomatoid granulomatosis

NIH research finds immunotherapy considerably will increase survival for folks with lymphomatoid granulomatosis

Press launch Tuesday, April 4, 2023 Outcomes of a scientific trial by Nationwide Institutes of Well being (NIH) researchers present that individuals with low-grade lymphomatoid granulomatosis who’re handled with interferon alfa-2b, a sort of immunotherapy, can dwell for many years after analysis. Lymphomatoid granulomatosis is a uncommon precancerous situation triggered by an infection with the…

Read More